177Lu-DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic/inoperable phaeochromocytomas and paragangliomas and focus on the impact of genetic variations in SDHx mutation on treatment outcomes - A single centre retrospective analysis of experience at an ENETS Centre of Excellence

Endocrine Abstracts(2023)

Cited 0|Views11
No score
Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
More
Translated text
Key words
paragangliomas,metastatic/inoperable phaeochromocytomas,sdhx mutation,lu-dotatate
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined